Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.
Cuchacovich M, Soto L, Edwardes M, Gutierrez M, Llanos C, Pacheco D, Sabugo F, Alamo M, Fuentealba C, Villanueva L, Gatica H, Schiattino I, Salazaro L, Catalan D, Valenzuela O, Salazar-Onfray F, Aguillón JC.
Cuchacovich M, et al. Among authors: valenzuela o.
Scand J Rheumatol. 2006 Nov-Dec;35(6):435-40. doi: 10.1080/03009740600904284.
Scand J Rheumatol. 2006.
PMID: 17343250